best area to inject tirzepatide Comprehensive Guide Subcutaneous Self-Injection Of Where to Inject Tirzepatide for

In the head-to-head SURMOUNT-5 trial (NEJM, 2025), tirzepatide produced 20.2% body weight loss vs 13.7% for semaglutide at 72 weeks, with similar side-effect profiles

The increased dosage used in Wegovy has been carefully tested and shown to safely promote more substantial reductions in body weight, making it an ideal option for aesthetic patients looking for effective solutions to improve their appearance, confidence, and overall health

Nausea occurs in 25-35% of users during dose escalation phases

& Centre for Research Excellence in Diabetic Retinopathy Study Group

On social media platforms like TikTok and Instagram, influencers have discussed hair loss as a side effect of Ozempic